← Eichor
Study identifier: NCT05090345 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).

Condition: Hematopoietic Cell Transplantation  ·  Sponsor: Duke University

PhaseN/A
Planned participants500
Who can joinAll sexes, 0 Years to 26 Years
Healthy volunteersNo

About this study

This is a prospective international multi-center registry and biorepository trial of children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT) to assess the impact of endotheliopathies in the HCT setting as a contributor of significant morbidity and mortality.

This description comes directly from the study's public registry record.

Talk to the study team

LaTarsha Spencer  ·  (919) 613-1895  ·  latarsha.spencer@duke.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Mayo ClinicRochester, Minnesota, United StatesRecruiting
Duke UniversityDurham, North Carolina, United StatesRecruiting
MD Anderson Cancer CenterHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05090345